Your browser doesn't support javascript.
loading
Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders.
Tsai, Daniel Hsiang-Te; Bell, J Simon; Abtahi, Shahab; Baak, Brenda N; Bazelier, Marloes T; Brauer, Ruth; Chan, Adrienne Y L; Chan, Esther W; Chen, Haoqian; Chui, Celine S L; Cook, Sharon; Crystal, Stephen; Gandhi, Poonam; Hartikainen, Sirpa; Ho, Frederick K; Hsu, Shao-Ti; Ilomäki, Jenni; Kim, Ju Hwan; Klungel, Olaf H; Koponen, Marjaana; Lau, Wallis C Y; Lau, Kui Kai; Lum, Terry Y S; Luo, Hao; Man, Kenneth K C; Pell, Jill P; Setoguchi, Soko; Shao, Shih-Chieh; Shen, Chin-Yao; Shin, Ju-Young; Souverein, Patrick C; Tolppanen, Anna-Maija; Wei, Li; Wong, Ian C K; Lai, Edward Chia-Cheng.
Afiliación
  • Tsai DH; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Bell JS; Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Abtahi S; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Baak BN; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • Bazelier MT; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands.
  • Brauer R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • Chan AYL; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
  • Chan EW; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
  • Chen H; Groningen Research Institute of Pharmacy, Unit of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, the Netherlands.
  • Chui CSL; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Cook S; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, Special Administrative Region, People's Republic of China.
  • Crystal S; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, Special Administrative Region, People's Republic of China.
  • Gandhi P; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Hartikainen S; Department of Pharmacy, the University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Ho FK; The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, People's Republic of China.
  • Hsu ST; Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Rutgers University, New Brunswick, NJ, USA.
  • Ilomäki J; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, Special Administrative Region, People's Republic of China.
  • Kim JH; School of Nursing, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Klungel OH; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Koponen M; Center for Health Services Research, Rutgers University, New Brunswick, NJ, USA.
  • Lau WCY; Center for Health Services Research, Rutgers University, New Brunswick, NJ, USA.
  • Lau KK; Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Rutgers University, New Brunswick, NJ, USA.
  • Lum TYS; Kuopio Research Centre of Geriatric Care and School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Luo H; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Man KKC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Pell JP; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Setoguchi S; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
  • Shao SC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • Shen CY; Kuopio Research Centre of Geriatric Care and School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Shin JY; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
  • Souverein PC; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Tolppanen AM; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong, Special Administrative Region, People's Republic of China.
  • Wei L; Division of Neurology, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Wong ICK; State Key Laboratory of Brain and Cognitive Sciences, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Lai EC; Department of Social Work and Social Administration, University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
Clin Epidemiol ; 15: 1241-1252, 2023.
Article en En | MEDLINE | ID: mdl-38146486
ABSTRACT

Purpose:

To describe and categorize detailed components of databases in the Neurological and Mental Health Global Epidemiology Network (NeuroGEN).

Methods:

An online 132-item questionnaire was sent to key researchers and data custodians of NeuroGEN in North America, Europe, Asia and Oceania. From the responses, we assessed data characteristics including population coverage, data follow-up, clinical information, validity of diagnoses, medication use and data latency. We also evaluated the possibility of conversion into a common data model (CDM) to implement a federated network approach. Moreover, we used radar charts to visualize the data capacity assessments, based on different perspectives.

Results:

The results indicated that the 15 databases covered approximately 320 million individuals, included in 7 nationwide claims databases from Australia, Finland, South Korea, Taiwan and the US, 6 population-based electronic health record databases from Hong Kong, Scotland, Taiwan, the Netherlands and the UK, and 2 biomedical databases from Taiwan and the UK.

Conclusion:

The 15 databases showed good potential for a federated network approach using a common data model. Our study provided publicly accessible information on these databases for those seeking to employ real-world data to facilitate current assessment and future development of treatments for neurological and mental disorders.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Clin Epidemiol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Clin Epidemiol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán